208136/017

Clinical Study ID

208136/017 (MeMuRu-OKA-017)

Study Title

Study to assess immunogenicity, reactogenicity and safety of a second dose of GlaxoSmithKline Biologicals’ measles-mumps-rubella-varicella (MeMuRu-OKA) vaccine given in healthy children of 5 to 6 years of age